Covered recipient · General Payments record
MARA SUZANNE EDISON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2021
$272.62
- Reported across 17 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $243.35 | 15 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $54.21 | 3 |
| EISAI INC. | $38.54 | 2 |
| Lilly USA, LLC | $31.23 | 2 |
| Novo Nordisk AS | $30.92 | 2 |
| Amarin Pharma Inc. | $30.47 | 2 |
| Amgen Inc. | $20.00 | 1 |
| Biohaven Pharmaceuticals, Inc. | $13.35 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.54 | 1 |
| GlaxoSmithKline, LLC. | $12.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $21.03 | 01/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794394531 | CMS |
| AbbVie Inc. | $15.38 | 04/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794394533 | CMS |
| AbbVie Inc. | $17.80 | 05/24/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794394535 | CMS |
| Amarin Pharma Inc. | $15.27 | 01/26/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815279879 | CMS |
| Amarin Pharma Inc. | $15.20 | 03/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815279881 | CMS |
| Amgen Inc. | $20.00 | 04/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825573597 | CMS |
| Biohaven Pharmaceuticals, Inc. | $13.35 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 852483425 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $12.54 | 04/20/2021 | Food and Beverage | Undisputed | 01/23/2026 | 763357938 | CMS |
| Eisai Inc. | $19.27 | 02/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 817836013 | CMS |
| Eisai Inc. | $19.27 | 03/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 817862103 | CMS |
| GlaxoSmithKline, LLC. | $12.09 | 01/21/2021 | Food and Beverage | Undisputed | 01/23/2026 | 803123109 | CMS |
| Lilly USA, LLC | $15.33 | 01/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818640237 | CMS |
| Lilly USA, LLC | $15.90 | 05/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818631685 | CMS |
| Novo Nordisk Inc | $13.14 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811096225 | CMS |
| Novo Nordisk Inc | $17.78 | 06/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 810979371 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021
- Source files
- Dataset page · Bulk file · PY2020 , PY2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.